UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030300
Receipt number R000034603
Scientific Title Efficacy of early human milk fortification for very low birth weight infants
Date of disclosure of the study information 2017/12/11
Last modified on 2023/12/12 09:27:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of early human milk fortification for very low birth weight infants

Acronym

early human milk fortification

Scientific Title

Efficacy of early human milk fortification for very low birth weight infants

Scientific Title:Acronym

early human milk fortification

Region

Japan


Condition

Condition

very low birth weight infants

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compair early HMF and delayed HMF on safty and growth of VLBWI, after minimalizing individual difference of human milk component by targeted (individualized) HMF.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

anthropometric measurement at 37th week corrected gestation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Human milk fortification will be started when volume of enteral feeding reach 20ml/kg/day after age of day 3. Parenteral nutrition will be continued untill enteral feeding reach 120~140ml/kg/day. Then, targeted HMF will be started after 24 hours or more.

Interventions/Control_2

Human milk fortification will be started when volume of enteral feeding reach 100ml/kg/day, as in a conventional method. Parenteral nutrition will be continued untill enteral feeding reach 120~140ml/kg/day. Then, targeted HMF will be started after 24 hours or more.(Same as Intervention 1)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <

Age-upper limit

120 days-old >

Gender

Male and Female

Key inclusion criteria

very low birth weight infant(birth weight less than 1500g) who are born at Showa University Hospital

Key exclusion criteria

1) congenital anormally
2) surgical disease of gastrointestinal tract
3) sever asphixia (5min Apgar Score<3)
4) patients who were thouth to be inadequate candidate by attending physician.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Kazuo
Middle name
Last name Miyazawa

Organization

Showa University School of Medicin

Division name

Department of Pediatrics

Zip code

142-8666

Address

1-5-8, Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8565

Email

kitaba@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Tokuo
Middle name
Last name Miyazawa

Organization

Showa University School of Medicine

Division name

Department of Pediatrics

Zip code

142-8666

Address

1-5-8, Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8565

Homepage URL


Email

miyazawa.t@med.showa-u.ac.jp


Sponsor or person

Institute

Showa University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

Tel

03-3784-8022

Email

gakuji@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 12 Month 01 Day

Date of IRB

2017 Year 07 Month 27 Day

Anticipated trial start date

2017 Year 12 Month 11 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 07 Day

Last modified on

2023 Year 12 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034603


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name